Trial Profile
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 03 Jun 2016 New trial record
- 02 Jun 2016 Results of post-hoc subgroup analysis published in the Advances in Therapy